Find side effects reporting information at the bottom of this page
If you are a UK Healthcare Professional, please visit our Healthcare Professional website here

Please select to continue

Ofev® (nintedanib esilate) is used in the treatment of Idiopathic Pulmonary Fibrosis (IPF) or other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, referred to as Progressive Pulmonary Fibrosis below.

Please select the relevant option below to find out more information.

NP-GB-101815 V2October 2022